Your browser doesn't support javascript.
loading
Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC).
Capdevila, Jaume; Trigo, José Manuel; Aller, Javier; Manzano, José Luís; Adrián, Silvia García; Llopis, Carles Zafón; Reig, Òscar; Bohn, Uriel; Cajal, Teresa Ramón Y; Duran-Poveda, Manuel; Astorga, Beatriz González; López-Alfonso, Ana; Martínez, Javier Medina; Porras, Ignacio; Reina, Juan Jose; Palacios, Nuria; Grande, Enrique; Cillán, Elena; Matos, Ignacio; Grau, Juan Jose.
Afiliação
  • Capdevila J; Medical Oncology Department, Gastrointestinal and Endocrine Tumor Unit, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Trigo JM; Medical Oncology Department, University Hospital Virgen de la Victoria, Málaga, Spain.
  • Aller J; Endocrinology Department, University Hospital Puerta de Hierro, Madrid, Spain.
  • Manzano JL; Medical Oncology Department, Catalan Oncology Institute (ICO-Badalona), University Hospital Germans Trias y Pujol, Barcelona, Spain.
  • Adrián SG; Medical Oncology Department, University Hospital of Móstoles, Móstoles, Madrid, Spain.
  • Llopis CZ; Endocrinology and Nutrition Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Reig Ò; Medical Oncology Department, Translational Genomics and Targeted Therapeutics in Solid Tumors (IDIBAPS), Hospital Clínic of Barcelona, Barcelona, Spain.
  • Bohn U; Medical Oncology Department, University Hospital of Gran Canaria Doctor Negrín, Las Palmas, Spain.
  • Cajal TRY; Medical Oncology Department, University Hospital of Santa Creu i Sant Pau, Barcelona, Spain.
  • Duran-Poveda M; General and Endocrine Surgery Department, University Hospital Rey Juan Carlos, Madrid, Spain.
  • Astorga BG; Medical Oncology Department, University Hospital Virgen de las Nieves, Granada, Spain.
  • López-Alfonso A; Medical Oncology Department, University Hospital Infanta Leonor, Madrid, Spain.
  • Martínez JM; Medical Oncology Department, Hospital Virgen de la Salud, Toledo, Spain.
  • Porras I; Medical Oncology Department, University Hospital Reina Sofía, Córdoba, Spain.
  • Reina JJ; Medical Oncology Department, University Hospital Virgen Macarena, Sevilla, Spain.
  • Palacios N; Endocrinology Department, University Hospital Puerta de Hierro, Madrid, Spain.
  • Grande E; Medical Oncology Department, University Hospital Ramón y Cajal, Madrid, Spain.
  • Cillán E; Medical Oncology Department, University Hospital of Santa Creu i Sant Pau, Barcelona, Spain.
  • Matos I; Medical Oncology Department, Gastrointestinal and Endocrine Tumor Unit, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Grau JJ; Medical Oncology Department, University of Barcelona, Hospital Clínic of Barcelona, Barcelona, Spain.
Eur J Endocrinol ; 177(4): 309-317, 2017 Oct.
Article em En | MEDLINE | ID: mdl-28687563
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Inibidores de Proteínas Quinases / Imidazóis / Indazóis / Radioisótopos do Iodo Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Inibidores de Proteínas Quinases / Imidazóis / Indazóis / Radioisótopos do Iodo Idioma: En Ano de publicação: 2017 Tipo de documento: Article